ArticleAnnals of surgical oncology2026

Induction Therapy with Crizotinib Before Surgery for ROS1 Fusion-Positive Potentially Resectable Non-small Cell Lung Cancer.

Zuwei Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.